Variant report
Variant | esv3355006 |
---|---|
Chromosome Location | chr6:62662593-62667191 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs533380026 | chr6:62662596-62662597 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs149182495 | chr6:62662601-62662602 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs6455094 | chr6:62662622-62662623 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs551099771 | chr6:62662626-62662627 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs9345810 | chr6:62662651-62662652 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs9345811 | chr6:62662663-62662664 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs561542004 | chr6:62662716-62662717 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs9363573 | chr6:62662719-62662720 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs545965148 | chr6:62662720-62662721 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs547728996 | chr6:62662722-62662723 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192999807 | chr6:62662729-62662730 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs73482851 | chr6:62662750-62662751 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs184215791 | chr6:62662754-62662755 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs188411833 | chr6:62662771-62662772 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs191482926 | chr6:62662782-62662783 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538806820 | chr6:62662841-62662842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs554022235 | chr6:62662862-62662863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs375482877 | chr6:62662893-62662894 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs9453711 | chr6:62662938-62662939 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs542970151 | chr6:62662950-62662951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs139300366 | chr6:62662972-62662973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs141592723 | chr6:62663025-62663026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs147033450 | chr6:62663040-62663041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs115760468 | chr6:62663044-62663045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs9453714 | chr6:62663054-62663055 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs556115087 | chr6:62663083-62663084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs560343344 | chr6:62663127-62663128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148122705 | chr6:62663161-62663162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs549309917 | chr6:62663167-62663168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs9453717 | chr6:62663172-62663173 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs141880508 | chr6:62663178-62663179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs549530817 | chr6:62663179-62663180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570542829 | chr6:62663204-62663205 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs575693053 | chr6:62663205-62663206 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs116709599 | chr6:62663228-62663229 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs553985429 | chr6:62663290-62663291 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs565929187 | chr6:62663292-62663293 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs1553395 | chr6:62663298-62663299 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs554807997 | chr6:62663351-62663352 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs576260810 | chr6:62663352-62663353 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs544560543 | chr6:62663401-62663402 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs530464203 | chr6:62663406-62663407 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs556317648 | chr6:62663427-62663428 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs367600948 | chr6:62663447-62663448 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs556241496 | chr6:62663522-62663523 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs577696453 | chr6:62663546-62663547 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs545146479 | chr6:62663547-62663548 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs374088014 | chr6:62663582-62663583 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs574498366 | chr6:62663598-62663599 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs527836108 | chr6:62663607-62663608 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Lung cancer | 19547694 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 23813976 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Autism | 19492091 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:62575400-62667600 | Weak transcription | Primary B cells from cord blood | blood |
2 | chr6:62660800-62663200 | Weak transcription | Fetal Brain Male | brain |
3 | chr6:62661400-62662600 | Enhancers | Fetal Intestine Small | intestine |
4 | chr6:62661600-62662600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr6:62661600-62662800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr6:62662400-62663200 | Weak transcription | Fetal Intestine Large | intestine |
7 | chr6:62662600-62663600 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr6:62662600-62663600 | Weak transcription | Fetal Intestine Small | intestine |
9 | chr6:62662800-62663200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr6:62663200-62664200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr6:62663200-62664200 | Enhancers | Fetal Intestine Large | intestine |
12 | chr6:62663200-62664400 | Enhancers | Fetal Brain Male | brain |
13 | chr6:62663600-62664000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr6:62663600-62664200 | Enhancers | Fetal Intestine Small | intestine |
15 | chr6:62663800-62664200 | Enhancers | Brain Substantia Nigra | brain |
16 | chr6:62664000-62668200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
17 | chr6:62664200-62668000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
18 | chr6:62664400-62668000 | Weak transcription | Fetal Brain Male | brain |